PRRT2 c.148_149delinsAT ;(p.P50I)

Variant ID: 16-29824523-CC-AT

NM_145239.2(PRRT2):c.148_149delinsAT;(p.P50I)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Nifetepimine, a dihydropyrimidone, ensures CD4+ T cell survival in a tumor microenvironment by maneuvering sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA).

The Journal Of Biological Chemistry
Ghosh, Swatilekha S; Adhikary, Arghya A; Chakraborty, Samik S; Nandi, Pinki P; Mohanty, Suchismita S; Chakraborty, Supriya S; Bhattacharjee, Pushpak P; Mukherjee, Sanhita S; Putatunda, Salil S; Chakraborty, Srabasti S; Chakraborty, Arijit A; Sa, Gaurisankar G; Das, Tanya T; Sen, Parimal C PC
Publication Date: 2012-09-21

Variant appearance in text: PKC: p50I
PubMed Link: 22851172
Variant Present in the following documents:
  • Main text
View BVdb publication page



Phorbol ester-induced human cytomegalovirus major immediate-early (MIE) enhancer activation through PKC-delta, CREB, and NF-kappaB desilences MIE gene expression in quiescently infected human pluripotent NTera2 cells.

Journal Of Virology
Liu, Xiaoqiu X; Yuan, Jinxiang J; Wu, Allen W AW; McGonagill, Patrick W PW; Galle, Courtney S CS; Meier, Jeffery L JL
Publication Date: 2010-09

Variant appearance in text: PKC: p50i
PubMed Link: 20504934
Variant Present in the following documents:
  • Main text
View BVdb publication page